Literature DB >> 22521091

The trade-off between sensitivity and specificity of clinical protocols for identification of insignificant prostate cancer.

Theodorus H Van der Kwast.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22521091     DOI： 10.1016/j.eururo.2012.04.017

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  6 in total

1.  Insignificant disease among men with intermediate-risk prostate cancer.

Authors:  Sung Kyu Hong; Emily Vertosick; Daniel D Sjoberg; Peter T Scardino; James A Eastham
Journal:  World J Urol       Date:  2014-09-27       Impact factor: 4.226

2.  PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance.

Authors:  Francesco Cantiello; Giorgio Ivan Russo; Antonio Cicione; Matteo Ferro; Sebastiano Cimino; Vincenzo Favilla; Sisto Perdonà; Ottavio De Cobelli; Carlo Magno; Giuseppe Morgia; Rocco Damiano
Journal:  World J Urol       Date:  2015-07-21       Impact factor: 4.226

Review 3.  Prostate cancer screening and the management of clinically localized disease.

Authors:  Timothy J Wilt; Hashim U Ahmed
Journal:  BMJ       Date:  2013-01-29

Review 4.  Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview.

Authors:  Sergey Reva; Alexander Nosov; Roman Novikov; Sergey Petrov
Journal:  Int Sch Res Notices       Date:  2014-07-15

Review 5.  Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review.

Authors:  Thomas Feutren; Fernanda G Herrera
Journal:  Prostate Int       Date:  2018-03-27

Review 6.  The role of focal therapy in the management of localised prostate cancer: a systematic review.

Authors:  Massimo Valerio; Hashim U Ahmed; Mark Emberton; Nathan Lawrentschuk; Massimo Lazzeri; Rodolfo Montironi; Paul L Nguyen; John Trachtenberg; Thomas J Polascik
Journal:  Eur Urol       Date:  2013-06-06       Impact factor: 20.096
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.